Excitation-contraction coupling in skeletal muscle.
Caillé
J
J
Ildefonse
M
M
Rougier
O
O
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001150:Arsenazo III / Q000494:pharmacology; D001718:Birefringence; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002462:Cell Membrane / Q000502:physiology / Q000648:ultrastructure; D002463:Cell Membrane Permeability; D002712:Chlorides / Q000378:metabolism; D003445:Crustacea; D004533:Egtazic Acid / Q000494:pharmacology; D004553:Electric Conductivity; D004558:Electric Stimulation; D004594:Electrophysiology; D007473:Ion Channels / Q000187:drug effects / Q000502:physiology; D007700:Kinetics; D008564:Membrane Potentials; D008854:Microscopy, Electron; D008954:Models, Biological; D009119:Muscle Contraction; D009132:Muscles / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D009469:Neuromuscular Junction / Q000502:physiology / Q000648:ultrastructure; D011188:Potassium / Q000378:metabolism; D011199:Potentiometry; D012519:Sarcoplasmic Reticulum / Q000502:physiology / Q000648:ultrastructure; D012964:Sodium / Q000378:metabolism; D013779:Tetrodotoxin / Q000494:pharmacology
D002121:Calcium Channel Blockers; D002712:Chlorides; D007473:Ion Channels; D001150:Arsenazo III; D013779:Tetrodotoxin; D004533:Egtazic Acid; D012964:Sodium; D011188:Potassium; D002118:Calcium